Hemophilia A Without Inhibitors: Personalizing Therapy With Factor VIII Prophylaxis

Review multidisciplinary perspectives on leveraging clotting factor concentrates for prophylaxis of hemophilia A with downloadable slidesets from the Webcast at THSNA 2020.

Share

Program Content

Activities

Hemophilia A Factor VIII Tx
Understanding the New Treatment Era of Alternative Therapies for Patients With Hemophilia A
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2020

Expires: October 28, 2021

Monitoring PK  in Hemophilia A
Pharmacokinetics in Hemophilia Management and Personalization of Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2020

Expires: October 28, 2021

Hemophilia Complications
Complications in Patients Receiving Factor Replacement Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2020

Expires: October 28, 2021

<i>EP:</i> Hemophilia A
ExpressPoints: Personalizing Therapy With Factor VIII Prophylaxis in Hemophilia A
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2020

Expires: November 04, 2021

Activities

Using PK Profiling
How I Use Individual PK Profiling to Personalize Hemophilia Prophylaxis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2020

Expires: November 19, 2021

No activities added yet

Faculty

cover img faculity

Michael Callaghan, MD

Associate Professor
Department of Hematology
Wayne State University
Hematologist
Division of Hematology/Oncology
Childrens Hospital of Michigan
Detroit, Michigan

cover img faculity

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Division of Hematology
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

cover img faculity

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Takeda Pharm USA